Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease?
- 1 October 2021
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), 1439-1446
- https://doi.org/10.7326/m21-2596
Abstract
Balancing the benefits and harms of aspirin for primary prevention of atherosclerotic vascular disease is challenging. Two expert clinicians discuss and debate current guidelines, the appropriate r... Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the United States. Reducing ASCVD risk through primary prevention strategies has been shown to be effective; how...This publication has 33 references indexed in Scilit:
- Using the Coronary Artery Calcium Score to Guide Statin TherapyCirculation: Cardiovascular Quality and Outcomes, 2014
- Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developersBMC Medical Informatics and Decision Making, 2013
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskJournal of Invasive Cardiology, 2013
- Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).Journal of the American College of Cardiology, 2013
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionThe Lancet, 2013
- Effect of Including Cancer Mortality on the Cost-Effectiveness of Aspirin for Primary Prevention in MenJournal of General Internal Medicine, 2013
- Aspirin for the Primary Prevention of Cardiovascular Disease in WomenArchives of Internal Medicine, 2007
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenThe New England Journal of Medicine, 2005
- Using the Coronary Artery Calcium Score to Predict Coronary Heart Disease EventsArchives of Internal Medicine, 2004
- Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged AdultsJAMA, 2004